Biosimilars Market Expected To Reach $41.7 Billion By 2024

Biosimilars costly

According to a new report from Grand View Research, the biosimilars market is expected to reach $41.7 billion by 2024. With the US FDA approving several biosimilars recently, experts believe that access to the US market could help spur global biosimilars growth. Several prominent biologic drugs are nearing the end of their patent protection, and biosimilar challengers could reduce costs for government health programs worldwide.

Read the source article at PR Newswire

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>